RxDoctor Payments Data

Michael Vogelbaum, MD

Neurological Surgery · Tampa, FLNPI 1598732380

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $40,421 of the $56,071 with a category attached, or 72.1%. 11 manufacturers reported payments, led by AstraZeneca at 52.8% of the total. Reporting peaked in 2024 at $29,614 and has fallen 99.9% since, to $38 in 2025.

$56,071in general payments, 2019–2025

Across 33 payments — averaging $1699.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$30K
  • Servier Pharmaceuticals LLC$11K
  • Olympus America Inc.$11K
  • Blue Earth Diagnostics$3K
  • Biogen$1K
  • Olympus Corporation Of The Americas$194
  • plus $361 from 5 others
$806,429in research payments, 2019–2025

Across 8 payments — averaging $100,804 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$759K
  • Olympus Corporation Of The Americas$48K
  • Merck$157

What the payments were for

  • Consulting fees$40,42172%
  • Speaking & faculty fees$2,7505%
  • Travel & lodging$12,04321%
  • Food & beverage$8572%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,071 in reported general payments places this provider in the 80th percentile of 556 neurological surgery providers in Florida.

See all neurological surgery providers in Florida

Medicare billing

Part B allowed, 2024
$43,966
Medicare patients
29
Services billed
66

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →